Motivational strategies to help African Americans improve dialysis adherence
MoVE Trial: Motivational Strategies To Empower African Americans To Improve Dialysis Adherence
This study is testing whether motivational coaching can help African American patients stick to their hemodialysis treatment better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 176 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Vanderbilt University Medical Center Academic / other |
| Locations | 6 sites (Philadelphia, PA 19123, Pennsylvania and 5 other locations) |
| Trial ID | NCT05735743 on ClinicalTrials.gov |
What this trial studies
The MoVE Trial is a randomized clinical trial that tests the effectiveness of a culturally tailored motivational interviewing intervention delivered by trained health coaches to improve adherence to hemodialysis treatment among African American patients. Participants will be randomly assigned to either the intervention group, which receives motivational interviewing sessions, or a control group. The trial will follow patients for 24 weeks, during which they will complete surveys to assess their adherence and overall health outcomes. This approach aims to address the specific barriers faced by African Americans in adhering to dialysis treatment.
Who should consider this trial
Good fit: Ideal candidates for this study are African American adults aged 18 and older who have been receiving hemodialysis for more than 30 days and have demonstrated non-adherence to their treatment.
Not a fit: Patients who do not self-identify as African American or those with severe mental illness or terminal conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve dialysis adherence among African American patients, leading to better health outcomes.
How similar studies have performed: Other studies have shown success with motivational interviewing approaches in improving treatment adherence, suggesting that this method may be effective in this context as well.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * African American * Receiving hemodialysis treatments * Been on hemodialysis for more than 30 days * 18 years of age and older * Within a 2-month look back at the time of screening, patients who have missed at least one dialysis session or shortened at least one dialysis session by 15 minutes. Exclusion Criteria: * Not self-identified as African American * Impaired with mental status or severe illness * Non-English speaking * No documented evidence of dialysis treatment non-adherence * Missed or shortened treatments due to hospitalizations or excused travel * Terminal condition * Living in a nursing home/rehab * Planned transplant within the next 6 months * Planned conversion to peritoneal dialysis within the next 6 months
Where this trial is running
Philadelphia, PA 19123, Pennsylvania and 5 other locations
- Buttonwood DaVita Dialysis 449 N Broad St, — Philadelphia, PA 19123, Pennsylvania, United States (Recruiting)
- DaVita Philadelphia PMC Dialysis — Philadelphia, Pennsylvania, United States (Enrolling_by_invitation)
- DaVita University City Dialysis — Philadelphia, Pennsylvania, United States (Enrolling_by_invitation)
- Vanderbilt Dialysis Clinic — Nashville, Tennessee, United States (Completed)
- Dialysis Clinic, Inc. — Nashville, Tennessee, United States (Recruiting)
- Vanderbilt Dialysis Clinic East — Nashville, Tennessee, United States (Active_not_recruiting)
Study contacts
- Principal investigator: Ebele M Umeukeje, MD, MPH — Vanderbilt University Medical Center
- Study coordinator: Ebele M Umeukeje, MD, MPH
- Email: ebele.m.umeukeje@vumc.org
- Phone: 615 936 3283
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.